Adolescent Surgery Experience (ASE) Prospective Cohort Study: Postoperative Pain Trajectory, Opioid Use, and Satisfaction

AnesthesiologyPublished Prospective cohort study

Authors' conclusion

After major surgery, a high proportion of adolescents endorsed persistent pain in month 3 despite relative recovery satisfaction. In addition, an unanticipated number used opioids after resolution of severe pain for which opioids may be indicated.

Study context

Population
Adolescents undergoing select procedures associated with mild, moderate or severe postoperative pain, enrolled June 2022 to May 2023
Participants
340 adolescents · 141 major procedures
Outcome
Persistent pain
Follow-up
Month 3
Methodological detailstext-message surveys
  • Text-message surveys

Main finding

As reported in the abstract

Persistent surgical site pain, major procedures

Major procedures

57.9%

81 events

Observational data: associations, not effects.

Secondary outcomes

OutcomeOR (95% CI)
Persistent surgical site pain over time (per month)Odds declined by 25% each month0.75 (0.67–0.83)

Predictor of persistent surgical site pain: female sex

OR (95% CI)P value
Female sexOnly significant individual predictor1.95 (1.11–3.42)P = 0.02

Satisfaction with recovery ("unhappy" or "very unhappy") · month 3

"unhappy" or "very unhappy" with recovery, major procedures
9.2% (n = 13)

Time to resolution of severe pain (NRS 7 to 10)

Severe pain resolved within (days after surgery), major procedures
3 (IQR 1 to 6)

Prolonged opioid use (more than 2 weeks)

Prolonged opioid use in weeks 3 and 4, major procedures
39.6% (n = 44)

Mild and moderate pain procedures (subgroup)

Trends similar but decreased in magnitude

Original publication

Adolescent Surgery Experience (ASE) Prospective Cohort Study: Postoperative Pain Trajectory, Opioid Use, and Satisfaction. Anesthesiology. Published 22 September 2026. doi:10.1097/aln.0000000000006304

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.